Skip to content
Search

Latest Stories

Healthwatch England report reveals challenges faced by patients using pharmacies

Healthwatch England report reveals challenges faced by patients using pharmacies

Patients are receptive to Pharmacy First service, but some challenges must be overcome to achieve its full potential, says Healthwatch England 

A recent report from Healthwatch England has highlighted that while people highly value the accessibility of community pharmacies, both in terms of location and prompt service, they also encounter challenges in getting the most out of their pharmacy care experience.


The report titled ‘Pharmacy: What People’ is based on the research conducted by the organisation in November last year, involving 1,650 people who shared their experiences of pharmacy services in England.

It showed the country’s notable dependence on community pharmacies, with 72 per cent of respondents saying they have used a community pharmacy in the past three months.

Usage of online pharmacies is considerably lower than community pharmacies, with only 18 per cent of individuals having used an online pharmacy in the past three months, according to the report published on Tuesday (30 April).

However, closures of pharmacies, supply shortages and rising costs are negatively affecting patients using pharmacies.

Medicine shortages turned out to be a major issue, as 42 per cent of respondents reported experiencing problems getting medicine from their pharmacy in the past 12 months.

Almost one in four (24 per cent) people have experienced their pharmacy being out of the medicine(s) they need in the past 12 months, the report revealed.

Although 90 per cent of prescriptions in England are dispensed free of charge, the cost-of-living crisis impacts pharmacy usage. As per the report, five per cent of people have avoided taking up one or more NHS prescriptions because of the price.

Pharmacy closures, especially temporary closures, are also affecting people's health and care.

One in fifteen people experienced problems getting medicine in the past year because the pharmacy unexpectedly closed when they visited.

People are receptive to Pharmacy First

The research, which was conducted before the Pharmacy First service was launched in England, found that people were already open to the idea of going to a pharmacy rather than a GP for common conditions.

Pharmacy First was introduced in January 2024, empowering pharmacies to treat seven common conditions: earache, sore throat, sinusitis, impetigo, shingles, infected insect bite, uncomplicated urinary tract infections.

People were more likely to go to a pharmacy rather than a GP for five of the seven conditions. The exceptions were shingles and UTIs.

The report noted that while Pharmacy First can be successful in directing people away from the GP for these conditions, it must overcome some challenges to achieve its full potential.

“Raising awareness that pharmacies offer new services will be crucial to the success of Pharmacy First,” the report recommended, while also stressing the need for pharmacies to have private consultation spaces to ensure people feel comfortable talking about sensitive issues.

Recommendations from Healthwatch

Healthwatch is calling on the government to issue targeted communications to raise awareness of the Pharmacy First service, improve awareness and availability of prescription prepayment certificates to address prescription cost barriers, and undertake a review of the medicines supply chain to address shortages.

Also, it is urging the government to provide more support to pharmacy teams, including improved IT systems, more funding, action on workforce shortages, and support with pharmacy premises.

In the longer term, Healthwatch is calling for further expansion of Pharmacy First and a solution to ensure IT systems used across primary care are interoperable.

Comments from industry leaders

Commenting on the report, Janet Morrison, CEO of Community Pharmacy England, said: “Patients are at the heart of everything that community pharmacies do and this Healthwatch England project has provided some valuable insights into patients’ perspectives.

“It is no surprise to hear of the positive patient views of Pharmacy First, nor to see how much patients are being impacted by medicines supply issues. Despite being in crisis, community pharmacies are working incredibly hard to protect their patients from the impact of these pressures.”

She added that CPE will continue to work collaboratively with Healthwatch England and other organisations in their efforts to ensure sustainable funding and future service developments for community pharmacies.

Tase Oputu, chair of the Royal Pharmaceutical Society (RPS) England Board, commented that the report reflected the continued concern raised by its members about the impact of medicines shortages on patients and pharmacy teams.

She pressed upon the government to ease shortages by “updating medicines legislation to enable community pharmacists to make minor amendments to prescriptions to adjust the strength or formulation.”

“Pharmacists are really keen to use their skills to better support patients through new services such as Pharmacy First. As we ask pharmacy teams to do more, this must be backed up by enhanced communications and seamless IT systems, alongside sustainable funding and investment in the workforce,” Oputu said.

Gisela Abbam, chair of the General Pharmaceutical Council, noted that the recommendations from Healthwatch need careful consideration by “everyone working across pharmacy and the NHS in England, as well as the government.”

She added that the GPhC has initiated discussions on how to respond to the important issues raised in this report, and anticipates working closely with Healthwatch England going forward.

Nicola Stockmann, president, Association of Pharmacy Technicians UK described the report as “valuable” and said that APTUK is looking forward to collaborating with Healthwatch to “expand the focus for pharmacy technicians and the wider pharmacy team as part of the pharmacy workforce.”

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less